Subject | HR | CI 95% | P value |
---|---|---|---|
OS | |||
 Age | 0.331 | 0.160–0.683 | 0.003 |
 Tumor size | 0.262 | 0.098–0.699 | 0.007 |
 EQD2(point A) | 2.530 | 1.159–5.521 | 0.036 |
DFS | |||
 Age | 0.462 | 0.232–0.920 | 0.028 |
 EFI | 1.927 | 1.000–3.714 | 0.050 |
 EQD2(point A) | 2.949 | 1.379–6.306 | 0.005 |
LCR | |||
 Tumor size | 0.091 | 0.011–0.745 | 0.026 |
 Age | 0.266 | 0.084–0.843 | 0.024 |
 EQD2(point A) | 5.578 | 1.795–17.332 | 0.003 |
OFRFS | |||
 Concurrent chemotherapy | 2.738 | 1.248–6.009 | 0.012 |
 EFI | 3.287 | 1.369–7.892 | 0.008 |